Literature DB >> 8253525

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden.

P Pisani1, D M Parkin, J Ferlay.   

Abstract

This report presents worldwide estimates of annual mortality from all cancers and for 18 specific cancer sites around 1985. Crude and age-standardized mortality rates and numbers of deaths were computed for 24 geographical areas. Of the estimated 5 million deaths from cancer (excluding non-melanoma skin cancer), 56% occurred in developing countries. The most frequent neoplasm is lung cancer, accounting for 22% of cancer deaths in men. Among women breast cancer is the leading malignancy, accounting for 16% and 11% of all cancer deaths in developed and developing countries, respectively. In developing countries, cancer of the cervix uteri ranks first, breast cancer second. The second most frequent cause of death from cancer in both sexes is cancer of the stomach, followed by liver cancer in men and by colon/rectum cancer in women. Cancers of the colon/rectum and prostate maintain a high rank in men living in developed countries, while cancers of the lung, ovary and pancreas occupy similar ranks among women. In developing countries, cancers of the oesophagus and mouth/pharynx follow those previously mentioned in both sexes. If the estimated rates continue to prevail, increases in the numbers of deaths of 20.4% in developed and 18.1% in developing countries are expected by the year 2000, simply as a consequence of demographic trends towards ageing and population growth. Our results provide an indication of the potential impact of preventive practices. It is estimated that 20% of all cancer deaths (1 million) could be prevented by eliminating tobacco smoking. Mortality from cancers of the liver and uterine cervix, both major problems in developing countries, could be substantially reduced by immunization against hepatitis B virus infection and early detection through Pap smears, respectively.

Entities:  

Mesh:

Year:  1993        PMID: 8253525     DOI: 10.1002/ijc.2910550604

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  102 in total

1.  Intraperitoneal chemotherapy: biologic implications for clinical outcome.

Authors:  J M Daly
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

2.  The epidemiology of stomach cancer: correlating the past with the present. Socioeconomic influences in early life can influence mortality in adult life.

Authors:  D Forman; K J Goodman
Journal:  BMJ       Date:  2000-06-24

3.  Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.

Authors:  R B Roden; A Armstrong; P Haderer; N D Christensen; N L Hubbert; D R Lowy; J T Schiller; R Kirnbauer
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Cancer mortality-to-incidence ratios in Georgia: describing racial cancer disparities and potential geographic determinants.

Authors:  Sara E Wagner; Deborah M Hurley; James R Hébert; Chrissy McNamara; A Rana Bayakly; John E Vena
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

Review 5.  Immunotherapy in metastatic renal cell carcinoma.

Authors:  Karl Rohrmann; Michael Staehler; Nikolas Haseke; Alexander Bachmann; Christian G Stief; Michael Siebels
Journal:  World J Urol       Date:  2005-04-02       Impact factor: 4.226

6.  Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.

Authors:  Nimzing G Ladep; Shahid A Khan; Mary Me Crossey; Andrew V Thillainayagam; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Telomerase activity as a tumor marker in Indian women with cervical intraepithelial neoplasia and cervical cancer.

Authors:  Alpana Sharma; Medha Rajappa; Alpana Saxena; Manoj Sharma
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer.

Authors:  Maral Mokhtari; Amin Rezaei; Ali Ghasemi
Journal:  J Gastrointest Cancer       Date:  2015-06

9.  [Inhaled immunotherapy for pulmonary metastases of renal cell cancer].

Authors:  G Lümmen; M Schenck; C Börgermann; A Eisenhardt; F Vom Dorp; H Sperling; H Rübben
Journal:  Urologe A       Date:  2004-04       Impact factor: 0.639

Review 10.  Chemoprevention of colorectal cancer.

Authors:  M Langman; P Boyle
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.